Hepatitis-associated (Australia) antigen and Down's syndrome.

Area of Science:

• Hepatology
• Genetics
• Epidemiology

Background:

• Hepatitis-Associated Antigen (HAA) is a marker for Hepatitis B virus infection.
• Down syndrome is a genetic disorder associated with intellectual disability.
• Previous studies have explored potential links between HAA and various health conditions.

Purpose of the Study:

• To investigate the prevalence of Hepatitis-Associated Antigen (HAA) in patients with Down syndrome and other forms of mental retardation.
• To compare HAA frequencies across different institutional settings and geographical locations.
• To determine if maternal exposure to HAA is associated with the occurrence of Down syndrome.

Main Methods:

• Serological testing for Hepatitis-Associated Antigen (HAA) in patient cohorts.
• Comparison of HAA prevalence in Down syndrome patients versus those with other intellectual disabilities.
• Analysis of HAA frequency based on institutionalization status and geographic origin (Japan, US, Germany).
• Examination of HAA or anti-HAA presence in mothers of infants with Down syndrome.

Main Results:

• HAA was detected in 5.8% of patients with Down syndrome and 3.7% of patients with other intellectual disabilities.
• The frequency of HAA was higher in institutionalized patients (10.4%) compared to non-institutionalized patients (2.4%) with Down syndrome.
• HAA prevalence in Down syndrome patients was lower in Japan than in the United States or Germany.
• HAA was detected in 1.3% of mothers of infants with Down syndrome.

Conclusions:

• The prevalence of Hepatitis-Associated Antigen (HAA) varies among individuals with Down syndrome and other intellectual disabilities, influenced by institutionalization and geographic factors.
• Maternal exposure to HAA, indicated by the presence of HAA or anti-HAA, was not found to be associated with an increased risk of bearing a child with Down syndrome.